Bourdel F. , Lacan F., Doucet C., Pochet L., Caflish A., Masereel B., Pirotte B., Reboud-Ravaux M.
Oxobenzopyran derivatives as thrombin inhibitors, XVI International Symposium on Medicinal Chemistry, September 18-22, 2000, Bologna – Italy
Publications
Bensmaine, de Gramont A, Brienza S, Marty M, Levi F, Ducreux M, Francois E, Gamelin E, Bleiberg H, Bleuzen P, Simon J, Cvitkovic E.
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. Eur J Cancer. 2000 Dec;36(18):2335-43.
Hasbini A, Durdux C, Faivre S, Wasserman E, Taamma A, Armand JP, Raymond E, Cvitkovic E.
[Epidermoid carcinoma of the head and neck: contribution of chemotherapy in case of recurrence and locally advanced disease. Review of the literature. Ann Otolaryngol Chir Cervicofac. 2000 Dec;117(6):390-402. Review. French.
Hasbini A, Raymond E, Cvitkovic E, Eschwege F, Armand JP. Carcinoma of the nasopharynx.
Bull Cancer. 2000 Dec;Suppl 5:21-6. Review. French.
Delaloge S, Laadem A, Taamma A, Chouaki N, Cvitkovic E, Pautier P, Misset JL, Lhomme C.
Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer. Am J Clin Oncol. 2000 Dec;23(6):569-74.
Clikeo 